Publications & Presentations

Publications & Presentations

To learn more about our innovative technology:
Patient Acceptability of a Novel Upper Nasal Delivery System for Dihydroergotamine Mesylate Using the Precision Olfactory Delivery (POD®) Device – Results From the Open-label STOP 301 Trial

Poster presented at the 2020 American Headache Society (AHS) Virtual Annual Scientific Meeting. Authors: Stephen B. Shrewsbury, John Hoekman, Maria Jeleva. Objective: To report the safety, tolerability, exploratory efficacy, and patient acceptability of POD DHE mesylate (INP104) over 24 weeks…

READ MORE

When Pills Don’t Work: Disorders of Gastric Motility in Migraine

Poster presented at the 2020 American Headache Society (AHS) Virtual Annual Scientific Meeting. Authors: Sheena K. Aurora, Sutapa Ray, Stephen B. Shrewsbury, Linda Nguyen. Objective: Gastric stasis has long been implicated in association with migraine. In this abstract we review…

READ MORE

Does Dihydroergotamine Treat the “Whole Migraine”?

Poster presented at the 2020 American Headache Society (AHS) Virtual Annual Scientific Meeting. Authors: Sheena K. Aurora, Sutapa Ray, Kelsey Satterly, Stephen B. Shrewsbury and John Hoekman. Objective: To review the comparative pharmacology of acute treatments for migraine. Methods: A…

READ MORE